Translational Medicine
University Homepage
University Contact
University Search
The University of EdinburghSkip Navigation
University Logos

Wellcome Trust Scottish Translational Medicine and Therapeutics Initiative - STMTI

Welcome to STMTI

STMTI is a novel collaboration between the four Scottish Academic Medical Centres, funded by the Wellcome Trust, and with additional support from Pfizer Pharmaceuticals in a PhD programme to create a new cadre of academic clinicians with expertise in translational medicine and therapeutics.

STMTI offers novel posts in the post-MMC environment that offer the potential of ‘run-through’ PhD and clinical training for the aspiring academic clinician.

The latest round of recruiment has ended.  There are currently no vacancies within the Initiative.



News

MRC/Wellcome Trust Translational Pharmacology and Pathology Meeting

Thursday 29th May 2014

Following on from the success of last year's TMAT Day, we are pleased to announce that we will be hosting another meeting.  The meeting will be held in Glasgow on 29th May 2014.  Further details will be posted once they become available.



MRC/Wellcome Trust Translational Pharmacology and Pathology Meeting

Friday 1st March 2013

Wellcome Auditorium, Queen’s Medical Research Institute, Edinburgh


Scotland’s Chief Scientist, Professor Andrew Morris, participated in this event, which celebrated the UK’s novel integrated research training programmes in Clinical Pharmacology, Pathology and Translational Medicine and Therapeutics (TMAT), and showcased the exciting work undertaken by some of the UK’s best young clinical academics.  At the event, selected fellows from the MRC Scottish Clinical Pharmacology and Pathology Programme (Lead: Professor Iain McInnes), the North West England MRC Fellowship Scheme (Leads: Professor Munir Pirmohamed and Professor Chris Griffiths) and the Wellcome Trust’s Scottish Translational Medicine and Therapeutics Initiative (Lead: Professor David Webb) presented their work in progress, Professor Sir John Savill gave an overview of the MRC clinical fellowship programmes, Professor Paul Peter Tak (Head of Immunoinflammation Therapy, GSK) provided his perspective on clinical research in the 21st century and the leaders of the three initiatives gave brief descriptions of how each programme is organised, its themes, the number of fellows and industry relationships etc.  The day was a huge success, and something that we are looking to repeat, perhaps on an annual basis.  Watch this space for more details...

To view a copy of the 2013 meeting programme, please click here


Dr Shyamanga Borooah

Dr Shyamanga Borooah, an STMTI Fellow whose project focusses on macular degeneration, recently featured in the Edinburgh and Lothians Health Foundation Impact Report.  The report can be viewed here:

http://www.nhslothian.scot.nhs.uk/OurOrganisation/KeyDocuments/Documents/ELHF%20IMPACT%20REPORT.pdf


WTCRF Translational Pharmacology Course

STMTI organised a Translational Pharmacology Course through the WTCRF Education Core.  The course was held in Edinburgh between 25th and 29th June 2012.  It was particularly designed to teach the students on making the bridge between pre-clinical pharmacology and first-in-man studies.  The course included a series of high profile speakers.  Click here to view the course programme.


STMTI and MRC SCP3 Joint Launch

A Consortium of Scottish Clinical Medical Schools (Universities of Aberdeen, Dundee, Edinburgh and Glasgow) has recently been awarded funding to support two innovative PhD fellowship training schemes for clinicians.  The first is STMTI, for which Fellows have already been recruited in several centres, and we have launched our first fellowships this year.  The second is an award from the MRC, SCP3, for training of clinical pharmacologists and pathologists in translational research.

To mark these awards, we launched these initiatives, jointly, at the University of Edinburgh’s Queen's Medical Research Institute on Monday, 22nd November, 2010.  Professor Sir John Savill, MRC CEO-Elect, hosted the day, and Professor Garret FitzGerald gave a keynote talk on TMAT.  Leaders of the other Wellcome Trust TMAT centres also participated.

The speakers have kindly agreed to make copies of their presentations available on this website.  These may be helpful to those unable to attend the Launch, and those who attended but would like a closer look.  To view the presentations, please click on the speakers' names below:

Dr Peter Dukes - MRC
Professor Garret FitzGerald - University of Pennsylvania
Dr Allison Jeynes-Ellis - ABPI
Professor Iain McInnes - Director, SCP3/Deputy Director, STMTI
Professor David Webb - Director, STMTI/Deputy Director, SCP3
Professor Martin Wilkins - Imperial College
Dr John Williams - Wellcome Trust
Dr Steve Felstead - Pfizer


To view the programme, click here

For further information, please direct enquiries to stmti@ed.ac.uk


 

The University of EdinburghCollege Home

Last modified: 28 January 2014   2007 The University of Edinburgh